Published by Jessica Weisman-Pitts
Posted on March 28, 2025
Active Involvement of Several Companies Developing State-of-the-art Technologies for Orthopedic Implants: Fact.MR Report
Revenue from the global Orthopedic Implant Market is anticipated to reach US$ 85.17 billion in 2034, as stated in the recently updated industry analysis published by Fact.MR, a market research and competitive intelligence provider. The market has been analyzed to advance at 6.6% CAGR from 2024 to 2034.
Increased demand for metal-based orthopedic implants is attributed to their ability to effectively mimic ligaments or cartilages. Titanium is one of the popular metallic alloys used for producing implants. Each patient’s anatomy requires a customized joint implant. As such, increasing requirements for customized orthopedic implants are helping healthcare professionals offer more effective services.
Companies are developing state-of-the-art technologies to offer technologically progressive implantation solutions and create remunerative opportunities in the global market. However, some users are hesitant to opt for orthopedic implants due to their high cost, which is adversely impacting global market growth opportunities.
Nevertheless, advancements in diagnostic procedures for detecting bone density are opening new opportunity gates for providers of orthopedic implants. Governmental and commercial organizations are offering supportive reimbursement policies, which are pushing orthopedic patients to undergo transplantation facilities as and when required.
Receive a Tailored Analysis for Specific Research Solutions:https://www.factmr.com/connectus/sample?flag=S&rep_id=990
Orthopedic Implant Industry News & Trends:
To increase their market share, major players in the orthopedic implant industry are adopting a variety of creative strategies, including scientific breakthroughs, mergers, acquisitions, unconventional marketing techniques, and others.
As an example,
Key Takeaway from Orthopedic Implant Market Study
“Development of customized joint orthopedic implants according to the anatomy of different patients and matching FDA standards is assisting market players improve their business stance,” says Fact.MR analyst.
High Demand for Orthopedic Implant Procedures in Hospitals Backed by Favorable Reimbursement Policies
Global demand for orthopedic implant procedures in hospital settings is evaluated to increase at a CAGR of 6% and reach a market value of US$ 42.4 billion by the end of 2034. More patients are getting admitted to hospitals for their implantation surgery due to supportive reimbursement policies provided by commercial and governmental organizations. In addition, rising availability of advanced medical equipment and the presence of skilled healthcare providers attract more patients to hospitals for orthopedic implants as compared to other medical centers.
Get a Custom Analysis for Targeted Research Solutions:https://www.factmr.com/connectus/sample?flag=S&rep_id=990
Key Market Players:
Some of the leading companies manufacturing orthopedic implants include CeramTec, Globus Medical Inc., Arthrex, Johnson & Johnson, DJO Finance LLC, Zimmer Biomet Holdings, Smith & Nephew Plc., CONMED Corporation, B. Braun Melsungen AG, DePuy Synthes, Stryker Corporation, MicroPort Scientific Corporation, Lina Corporate S.p.A., ConforMIC, and Exatech Inc.
More Valuable Insights on Offer
Fact.MR, in its new offering, presents an unbiased analysis of the orthopedic implant market, presenting historical demand data (2019 to 2023) and forecast statistics for the period (2024 to 2034).
The study divulges essential insights into the market based on type (hip reconstruction (total hip reconstruction, partial hip reconstruction, revision implants), knee reconstruction [total knee reconstruction, partial knee reconstruction, revision implants], shoulder implants [anatomical shoulder prosthetic, reverse shoulder prosthetics], foot & ankle implants, elbow implants, hand & wrist implants, dental implants, spinal implants), material (metallic, ceramic, polymeric), and end user (hospitals, orthopedic clinics, ambulatory surgical centers, across seven major regions of the world (North America, Latin America, Western Europe, Eastern Europe, East Asia, South Asia & Pacific, and MEA).
Explore More Related Studies Published by Fact.MR Research:
Testosterone Booster Supplements Market is estimated to be valued at US$ 77.2 million in 2023. The global revenue are projected to grow at a CAGR of 6.4% by 2033.
Heart Health Supplement Market is expanding from an estimated $10.9 Bn in 2024 to a colossal $27.9 Bn by 2034, fueled by an impressive CAGR of 9.9%
The Recombinant Cell Culture Market is expanding from an estimated $2.87 billion in 2024 to a colossal $5.81 billion by 2034, fueled by a CAGR of 7.3%.
The Herbal Supplement Market is expanding from an estimated $1.36 billion in 2024 to a colossal $3.07 billion by 2034, fueled by an impressive CAGR of 8.5%.
Pet Allergy Immune Supplements Market to reach at US$ 254 Mn in 2023. The global industry is forecasted to grow at CAGR of 12.2% from 2023 to 2033
Psyllium-Based Supplement Market is pegged at US$ 1.48 Bn in 2023 and is forecasted to grow at a CAGR of 7.3% to reach a value of US$ 2.99 Bn by 2033.
Bone & Joint Health Supplement Market is expanding from an estimated $34.89 billion in 2024 to a colossal $71.91 billion by 2034, fueled by a CAGR of 7.5%.
Nutraceutical Supplement Market is expanding from an estimated $87.41 billion in 2024 to a colossal $201.75 billion by 2033, fueled by a CAGR of 5.9%.
Explore more articles in the Research Reports category
